Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Accumulated Depreciation & Amortization (2020 - 2026)

Bioventus filings provide 6 years of Accumulated Depreciation & Amortization readings, the most recent being $5.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 25.16% to $5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 25.16% decrease, with the full-year FY2025 number at $5.7 million, down 25.16% from a year prior.
  • Accumulated Depreciation & Amortization hit $5.7 million in Q4 2025 for Bioventus, up from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $9.7 million in Q4 2022 to a low of $1.4 million in Q3 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $2.3 million (2023), compared with a mean of $4.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 221.27% in 2022 and later plummeted 76.24% in 2025.
  • Bioventus' Accumulated Depreciation & Amortization stood at $8.4 million in 2021, then grew by 16.56% to $9.7 million in 2022, then decreased by 9.29% to $8.8 million in 2023, then dropped by 13.46% to $7.7 million in 2024, then decreased by 25.16% to $5.7 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $5.7 million (Q4 2025), $1.4 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.